Global perspective on pediatric growth hormone registries: a systematic review.

What It Covers

This systematic review looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Therefore, the purpose of this systematic review is to identify worldwide registries reported on pediatric GH treatment and to provide a summary of their main characteristics.

Basic information on pediatric GH registries, their type and scope, purpose, sources of data, target conditions, reported outcomes, and important variables were analyzed and presented.

Why It Was Studied

Registries are considered valuable data sources for identification of pediatric conditions treated with growth hormone (GH), and their follow-up.

Currently, there is no systematic literature review on the scope and characteristics of pediatric GH registries.

Who the Included Studies Covered

By PubMed's age tags, the people studied were children.

How the Review Was Done

Twenty two articles, reporting on 20 pediatric GH registries, were included in this review.

What Was Measured

This systematic review provides a global perspective on pediatric GH registries which can be used as a basis for the design and development of new GH registry systems at both national and international levels.

The subject headings attached to it are Dwarfism, Pituitary, Growth Disorders, Growth Hormone, Human Growth Hormone and Registries.

The authors tagged it with the keywords growth hormone treatment; registry, pediatrics and systematic review.

What This Means in Plain Language

This is a systematic review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 2022 (Journal of pediatric endocrinology & metabolism : JPEM), a journal based in Germany.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.